The price target for Zenas BioPharma (ZBIO) has been increased by 10.51%, reaching a new target of 44.44. This adjustment reflects a positive outlook on the company’s financial prospects and stock valuation.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Zenas BioPharma (ZBIO) Price Target Increased by 10.51% to 44.44
The price target for Zenas BioPharma (ZBIO) has been increased by 10.51%, reaching a new target of 44.44. This adjustment reflects a positive outlook on the company’s financial prospects and stock valuation.